Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

"Ultrasound vs. Landmark Technique for Spinal Anesthesia in Obese Women Undergoing Cesarean Section"

20. května 2026 aktualizováno: Kazi Mahzabin Arin, Bangladesh Medical University

Evaluation of Ultrasound Assisted Localisation of the Intervertebral Space Versus the Traditional Landmark Technique During Subarachnoid Block for Caesarean Section in Obese Parturient

The goal of this clinical trial is to evaluate whether the ultrasound-assisted technique improves the accuracy and safety of spinal anesthesia compared to the traditional landmark technique in obese women undergoing a cesarean section. The main questions it aims to answer are:

Does the ultrasound-assisted technique reduce the number of needle attempts required for successful spinal anesthesia? Does the ultrasound-assisted technique decrease the incidence of post-dural puncture headache (PDPH) and chronic low back pain at the needle insertion site? Does the ultrasound-assisted technique reduce procedure time compared to the landmark technique?

Participants will:

Receive spinal anesthesia using either the ultrasound-assisted technique or the traditional landmark technique for cesarean section.

Be monitored for the number of needle attempts, procedure time, and any post-operative complications such as PDPH or low back pain.

Follow up for three months after the procedure to assess any long-term effects, including chronic low back pain and quality of life.

Přehled studie

Detailní popis

This clinical trial is designed to compare two techniques for performing subarachnoid block (SAB) in obese women undergoing elective cesarean sections. The study aims to evaluate the effectiveness and safety of ultrasound-assisted spinal anesthesia versus the traditional landmark-guided technique. Both techniques are commonly used for regional anesthesia, but the effectiveness of ultrasound assistance in improving procedural accuracy, reducing complications, and enhancing the overall success rate in obese parturient has not been sufficiently studied.

Study Design

This is a randomized controlled trial conducted at the Obstetric Operating Theatre of Bangladesh Medical University (BMU). Participants will be randomly assigned to one of two groups: Group A (landmark technique) and Group B (ultrasound-assisted technique). The study will evaluate the following:

Primary Objective:

To assess the number of needle attempts required for successful subarachnoid block in both groups.

Secondary Objectives:

To evaluate the procedure time, incidence of post-dural puncture headache (PDPH), chronic low back pain at the needle insertion site, and quality of life related to pain.

Interventions

Both groups will receive the same local anesthetic agents for the SAB: 0.5% hyperbaric bupivacaine with 25 μg fentanyl. The techniques will differ in how the intervertebral space is located.

Group A (Landmark Technique): In this technique, the L3-L4 or L4-L5 intervertebral spaces will be identified using the traditional landmark method. The anesthesiologist will palpate the iliac crests to find Tuffier's line and will estimate the intervertebral space based on these bony landmarks.

Group B (Ultrasound-Assisted Technique): In this group, ultrasound guidance will be used to locate the intervertebral space. A low-frequency (2-5 MHz) curvilinear probe will be employed to visualize the lumbar spine. The procedure will include scanning the area to identify the midline, the interlaminar spaces, and the depth of the epidural and spinal spaces, ensuring that the correct intervertebral level is identified before needle insertion.

Randomization

Participants will be randomly assigned to one of the two intervention groups using Block randomization schedule. This will ensure that both groups are comparable at baseline and that the results are unbiased.

Procedure

Before the procedure, participants will undergo routine preoperative assessment, including fasting for 6 hours, intravenous line establishment, and monitoring. They will be positioned in a sitting position with a pillow for lumbar flexion. After preparing the skin with aseptic techniques, the spinal needle will be inserted according to the assigned technique.

In Group A, after identifying the L3-L4 or L4-L5 intervertebral space using the landmark technique, the anesthesiologist will administer the Subarachnoid Block (SAB). In Group B, ultrasound will be used to precisely identify the lumbar intervertebral spaces before needle insertion.

Follow-Up

Participants will be monitored for immediate postoperative complications, including Postdural puncture headache (PDPH), and will be assessed for chronic low back pain at the needle insertion after 3 months over phone. Additionally, the quality of life related to low back pain will be evaluated via phone interviews.

Expected Outcomes

The primary hypothesis is that the ultrasound-assisted technique will result in fewer needle attempts and a more accurate identification of the intervertebral space compared to the traditional landmark technique. Additionally, investigators expect to find that ultrasound assistance reduces the incidence of Postdural puncture headache (PDPH) and chronic low back pain, thereby improving the patient's overall quality of life postoperatively.

This trial will provide valuable insights into the effectiveness of ultrasound in improving the safety and accuracy of Subarachnoid Block (SAB) in obese parturient, potentially changing the standard of care in obstetric anesthesia for this patient population.

Typ studie

Intervenční

Zápis (Aktuální)

60

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

      • Dhaka, Bangladéš, 1000
        • Bangladesh Medical University

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dítě
  • Dospělý
  • Starší dospělý

Přijímá zdravé dobrovolníky

Ne

Popis

Inclusion Criteria:

  • Elective caesarean section
  • ASA physical status: Ⅱ
  • Obese parturient (BMI ≥ 30.1 kg/m²)

Exclusion Criteria:

  • Allergic to local anaesthetic (0.5% Bupivacaine hydrochloride with 8% Dextrose and 2 % Lidocaine hydrochloride USP)
  • Preexisting neurological deficit by clinical examination
  • Any contraindication to SAB
  • History of scoliosis or spinal instrumentation
  • Allergy to ultrasound transmission gel

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Jiný
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Aktivní komparátor: Group A: Landmark-Guided Spinal Anesthesia
In this arm, participants will receive subarachnoid block using the traditional landmark technique for spinal anesthesia. The L3-L4 or L4-L5 intervertebral space will be identified by palpating the iliac crests to locate Tuffier's line, and the spinal needle will be inserted based on these bony landmarks. The anesthetic agents administered will be 0.5% hyperbaric bupivacaine (10 mg) and 25 μg fentanyl (0.5 mL). The procedure will be performed by experienced anesthesiologists.
This intervention involves the use of traditional anatomical landmarks to locate the correct intervertebral space for performing subarachnoid block (SAB). The anesthesiologist identifies the L3-L4 or L4-L5 intervertebral space by palpating the iliac crests and using Tuffier's line as a reference. A 25G Quincke needle is used for SAB, and 0.5% hyperbaric bupivacaine with 25 μg fentanyl is administered. This technique is the standard approach used in many clinical settings for spinal anesthesia.
Experimentální: Group B: Ultrasound-Assisted Spinal Anesthesia
In this arm, participants will receive subarachnoid block using the ultrasound-assisted technique. A low-frequency (2-5 MHz) curvilinear probe will be used to visualize the lumbar spine and identify the intervertebral space. The correct intervertebral space (L3-L4 or L4-L5) will be identified using real-time ultrasound imaging. The anesthetic agents administered will be 0.5% hyperbaric bupivacaine (10 mg) and 25 μg fentanyl (0.5 mL). This procedure will also be performed by experienced anesthesiologists with expertise in neuraxial ultrasound.
This intervention utilizes ultrasound guidance to identify the correct intervertebral space for performing subarachnoid block (SAB). A low-frequency (2-5 MHz) curvilinear ultrasound probe is used to visualize the lumbar spine in real-time, ensuring precise identification of the L3-L4 or L4-L5 intervertebral space. The anesthesiologist places the needle based on ultrasound images that show the anatomical structures, such as the spinous processes and interlaminar spaces. The same anesthetic agents (0.5% hyperbaric bupivacaine and 25 μg fentanyl) are administered through a 25G Quincke needle for SAB.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Number of Needle Attempts for Successful Subarachnoid Block
Časové okno: During the procedure, until successful spinal needle placement
his is the key measure in your study, as it directly assesses the effectiveness of the two anesthesia techniques (ultrasound-assisted vs. landmark-guided) in achieving successful spinal anesthesia. Fewer needle attempts would indicate a higher success rate and a more efficient technique, making it the most critical outcome for evaluating the interventions.
During the procedure, until successful spinal needle placement

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Needle Insertion Site Accuracy in landmark technique group
Časové okno: Immediately after transferring the participants in the recovery room
This measure evaluates whether the correct intervertebral space was identified and the needle was inserted at the intended location. Accuracy will be assessed using ultrasound imaging in the recovery room to verify the spinal leve
Immediately after transferring the participants in the recovery room
Procedure Duration in minutes
Časové okno: During procedure
This outcome will assess the time taken to perform the spinal anesthesia procedure from the beginning of patient positioning for spinal anaesthesia to the successful Spinal Needle insertion.
During procedure
Incidence of Post-Dural Puncture Headache (PDPH)
Časové okno: Postoperative period (up to 72 hours)
The incidence of PDPH will be recorded in the immediate postoperative period. Participants will be monitored for symptoms such as headache, nausea, and neck stiffness, which are common after dural puncture.
Postoperative period (up to 72 hours)
Chronic Low Back Pain at Needle Insertion Site
Časové okno: 3 months post-procedure
Chronic low back pain at the needle insertion site will be evaluated via phone follow-up using the Numerical Rating Scale (NRS) to assess pain intensity. The impact on daily activities, including work, sleep disturbances, and mobility, will also be documented
3 months post-procedure
Impact of Chronic Low Back Pain on Quality of Life
Časové okno: 3 months post-procedure

Quality of life is assessed using the 12-Item Short Form Health Survey (SF-12), a validated, widely used questionnaire measuring health-related quality of life across two domains:

Physical Component Summary (PCS): captures physical functioning, bodily pain, and general physical health.

Mental Component Summary (MCS): captures emotional well-being, social functioning, vitality, and mental health.

Responses are collected via phone interview by trained study staff. Data are coded according to Short-Form-12 (SF-12) guidelines and aggregated into summary scores.

Score Range: 0-100, with higher scores indicating better quality of life (less limitation or distress).

3 months post-procedure

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Ředitel studie: AKM Akhtaruzzaman, MD, Bangladesh Medical University

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Užitečné odkazy

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

1. února 2025

Primární dokončení (Aktuální)

30. srpna 2025

Dokončení studie (Aktuální)

30. listopadu 2025

Termíny zápisu do studia

První předloženo

8. května 2026

První předloženo, které splnilo kritéria kontroly kvality

15. května 2026

První zveřejněno (Aktuální)

22. května 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

22. května 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

20. května 2026

Naposledy ověřeno

1. května 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • 5294

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit